Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383900935> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4383900935 endingPage "30" @default.
- W4383900935 startingPage "23" @default.
- W4383900935 abstract "Background: Vaccination is considered to be the most effective way of preventing influenza related-illnesses and their complications, which is particularly important in elderly population (aged 65+), often characterized with more rapid and severe clinical course of infection. Quadrivalent influenza vaccines (QIV) have been developed to avoid the poor antigenic match observed in the trivalent formulation vaccine (TIV). Methods: The study assess the immunogenicity, cost-effectiveness and impact on the Polish budget of inactivated quadrivalent influenza vaccine (VaxigripTetra), assuming its reimbursement in the active immunization of adults 65 years of age and older. Results: As clinical results have shown, non-inferior immunogenicity of QIV to each TIV for the shared strains and superior immunogenicity of QIV to each TIV for the alternate B strain. The inactivated QIV was well tolerated. VaxigripTetra is a highly cost-effective option compared to the strategy of “no vaccination” (ICUR=14,988 PLN/QALY – payer’s + patients’ perspective [PPP+P], ICUR=6,838 PLN/QALY – payers’ perspective [PPP]) and also to TIV (ICUR=121,418 PLN or ICUR=114,360 PLN, respectively). The increase of the public payer’s expenditures – 9.0-23.3 million PLN annually – will result in additional health effects: 1,091 – 4,805 GP visits, 175-771 hospitalizations and 74-326 deaths avoided per year. Conclusions: VaxigripTetra reimbursement could trigger a faster switch from TIVs to QIVs and at the same time could increase the vaccine coverage of the elderly population in Poland, which would lessen the ILI-related negative impact on that population at a reasonable cost to the healthcare system, while providing some savings to society." @default.
- W4383900935 created "2023-07-12" @default.
- W4383900935 creator A5012137103 @default.
- W4383900935 creator A5050353634 @default.
- W4383900935 creator A5090405737 @default.
- W4383900935 date "2018-03-20" @default.
- W4383900935 modified "2023-10-06" @default.
- W4383900935 title "VaxigripTetra (Quadrivalent Influenza Vaccine) – evidence for clinical and economic benefits from vaccination in population aged 65 and over in Poland" @default.
- W4383900935 doi "https://doi.org/10.7365/jhpor.2017.2.3" @default.
- W4383900935 hasPublicationYear "2018" @default.
- W4383900935 type Work @default.
- W4383900935 citedByCount "0" @default.
- W4383900935 crossrefType "journal-article" @default.
- W4383900935 hasAuthorship W4383900935A5012137103 @default.
- W4383900935 hasAuthorship W4383900935A5050353634 @default.
- W4383900935 hasAuthorship W4383900935A5090405737 @default.
- W4383900935 hasBestOaLocation W43839009351 @default.
- W4383900935 hasConcept C147483822 @default.
- W4383900935 hasConcept C160735492 @default.
- W4383900935 hasConcept C162324750 @default.
- W4383900935 hasConcept C187212893 @default.
- W4383900935 hasConcept C203014093 @default.
- W4383900935 hasConcept C22070199 @default.
- W4383900935 hasConcept C2779703844 @default.
- W4383900935 hasConcept C2780689484 @default.
- W4383900935 hasConcept C2780868878 @default.
- W4383900935 hasConcept C2908647359 @default.
- W4383900935 hasConcept C50522688 @default.
- W4383900935 hasConcept C71924100 @default.
- W4383900935 hasConcept C99454951 @default.
- W4383900935 hasConceptScore W4383900935C147483822 @default.
- W4383900935 hasConceptScore W4383900935C160735492 @default.
- W4383900935 hasConceptScore W4383900935C162324750 @default.
- W4383900935 hasConceptScore W4383900935C187212893 @default.
- W4383900935 hasConceptScore W4383900935C203014093 @default.
- W4383900935 hasConceptScore W4383900935C22070199 @default.
- W4383900935 hasConceptScore W4383900935C2779703844 @default.
- W4383900935 hasConceptScore W4383900935C2780689484 @default.
- W4383900935 hasConceptScore W4383900935C2780868878 @default.
- W4383900935 hasConceptScore W4383900935C2908647359 @default.
- W4383900935 hasConceptScore W4383900935C50522688 @default.
- W4383900935 hasConceptScore W4383900935C71924100 @default.
- W4383900935 hasConceptScore W4383900935C99454951 @default.
- W4383900935 hasIssue "2" @default.
- W4383900935 hasLocation W43839009351 @default.
- W4383900935 hasOpenAccess W4383900935 @default.
- W4383900935 hasPrimaryLocation W43839009351 @default.
- W4383900935 hasRelatedWork W2014690629 @default.
- W4383900935 hasRelatedWork W2015260696 @default.
- W4383900935 hasRelatedWork W2016605117 @default.
- W4383900935 hasRelatedWork W2019414446 @default.
- W4383900935 hasRelatedWork W2019574320 @default.
- W4383900935 hasRelatedWork W2029074520 @default.
- W4383900935 hasRelatedWork W2061876279 @default.
- W4383900935 hasRelatedWork W2466910529 @default.
- W4383900935 hasRelatedWork W2751942428 @default.
- W4383900935 hasRelatedWork W4308302287 @default.
- W4383900935 isParatext "false" @default.
- W4383900935 isRetracted "false" @default.
- W4383900935 workType "article" @default.